Clarke, Brian https://orcid.org/0000-0002-6695-286X
Holtkamp, Eva https://orcid.org/0000-0002-2129-9908
Öztürk, Hakime https://orcid.org/0000-0002-2146-5638
Mück, Marcel https://orcid.org/0009-0000-3129-2630
Wahlberg, Magnus https://orcid.org/0009-0001-9140-2392
Meyer, Kayla https://orcid.org/0009-0003-5063-5266
Munzlinger, Felix
Brechtmann, Felix https://orcid.org/0000-0002-0110-152X
Hölzlwimmer, Florian R.
Lindner, Jonas
Chen, Zhifen
Gagneur, Julien https://orcid.org/0000-0002-8924-8365
Stegle, Oliver https://orcid.org/0000-0002-8818-7193
Article History
Received: 10 July 2023
Accepted: 20 August 2024
First Online: 25 September 2024
Competing interests
: O.S. is a paid advisor of Insitro. B.C. holds equity in Tachyon Therapeutics. The other authors declare no competing interests.